Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aethlon Medical, Inc.
The Aethlon Hemopurifier Proves Effective in Capturing the Reconstructed Spanish Flu of 1918 and H5N1 Avian Influenza Virus
June 20th, 2008
Aethlon Medical, Inc. (OTCBB:AEMD) announced that the Aethlon Hemopurifier(R) has proven effective in capturing the reconstructed Spanish Flu of 1918 virus (1918rv). During in vitro testing, high concentrations of 1918rv were rapidly depleted from cell culture fluid when circulated through the Hemopurifier(R). The study documented that 76 percent of 1918rv was removed from circulation during the first two hours, and by the end of the sixth hour, 93 percent of 1918rv was cleared from circulation. The study data was quantified by reverse transcription polymerase chain reaction (PCR). The Spanish Flu of 1918 is believed to have caused 40-50 million deaths during a two-year time span. The...
Source: Health Business Week (2008-06-20)
|
|
Advertisement |
|
|
|
